Prise en charge d’une allergie à l’héparine : un casereport et une revue de la littérature

Abstract

Heparins are anticoagulants used in the prevention of thromboembolic events. Adverse reactions identified for this drug class include allergies. These can take different forms and involve, when they occur in a patient, appropriate management. We report the case of a patient operated on for a revision of a total hip replacement with a history of allergy to heparin. Given the urgency of the operation, no clinical or biological investigation could be carried out to verify the allergy. The patient was therefore placed on danaparoid sodic and apixaban has been introduced to prevent thromboembolic risk, although this is not the standard treatment for patients with a history of allergy to heparin.